Dorchy H, Despontin M, Haumont D, Toussaint D, De Vroede M, Loeb H
Sem Hop. 1982 Dec 23;58(47):2773-80.
The measurement of HbA1 gives an "objective" estimate of the degree of metabolic control of diabetes during the erythrocyte lifespan. 333 assays in 85 young diabetics aged three to twenty-three years showed a mean HbA1 of 10.9 +/- 2.6% (controls: 7.4 +/- 1.4%). HbA1 levels parallel the clinical evaluation of the degree of control. HbA1 concentrations are correlated with the duration of diabetes (r = 0.26; p less than 0.001), triglyceridemia (r = 0.22; p less than 0.001), cholesterolemia (r = 0.26; p less than 0.001) and glycemia (r = 0.50; p less than 0.001). The HbA1 glycemia correlation grows stronger as glycemia increases. This probably reflects the existence of a labile form of HbA1. HbA1 concentrations measured repeatedly over one year were not significantly different in diabetics with and without retinopathy, probably because the study period was too short. Measurement of HbA1 is also of value in diagnosing non-compliance.
糖化血红蛋白(HbA1)的测定可对红细胞寿命期间糖尿病的代谢控制程度作出“客观”评估。对85名年龄在3至23岁的年轻糖尿病患者进行的333次检测显示,糖化血红蛋白的平均水平为10.9±2.6%(对照组为7.4±1.4%)。糖化血红蛋白水平与控制程度的临床评估结果相符。糖化血红蛋白浓度与糖尿病病程(r = 0.26;p < 0.001)、甘油三酯血症(r = 0.22;p < 0.001)、胆固醇血症(r = 0.26;p < 0.001)及血糖(r = 0.50;p < 0.001)相关。随着血糖升高,糖化血红蛋白与血糖的相关性增强。这可能反映出存在一种不稳定形式的糖化血红蛋白。在患有和未患视网膜病变的糖尿病患者中,对糖化血红蛋白浓度进行的为期一年的重复测量结果无显著差异,这可能是因为研究期过短。糖化血红蛋白的测定对于诊断治疗依从性不佳也有价值。